US Equity
MYGN
— MYRIAD GENETICS, INC.Myriad Genetics, Inc. is a molecular diagnostics company that develops and commercializes genetic testing products for hereditary cancer, reproductive health, and other conditions.
💰 Market cap: $514.74M📍 322 North 2200 West, SALT LAKE CITY, UT, 84116 US🏷️ Healthcare Equipment & Supplies💵 Previous close: $5.61🔢 9,760 credits left
Add Column
All
Trend
| Date ▾ | Close ▾ |
|---|---|
| 2026-07-24 | $5.61 |
| 2026-07-23 | $5.70 |
| 2026-07-22 | $5.66 |
| 2026-07-21 | $5.91 |
| 2026-07-20 | $5.92 |
| 2026-07-17 | $6.18 |
| 2026-07-16 | $6.19 |
| 2026-07-15 | $6.31 |
| 2026-07-14 | $6.04 |
| 2026-07-13 | $5.86 |
| 2026-07-10 | $5.83 |
| 2026-07-09 | $6.10 |
| 2026-07-08 | $5.87 |
| 2026-07-07 | $5.86 |
| 2026-07-06 | $6.03 |
| 2026-07-02 | $5.99 |
| 2026-07-01 | $6.00 |
| 2026-06-30 | $5.71 |
| 2026-06-29 | $5.85 |
| 2026-06-26 | $5.88 |
| 2026-06-25 | $5.43 |
| 2026-06-24 | $5.22 |
| 2026-06-23 | $4.63 |
| 2026-06-22 | $4.50 |
| 2026-06-18 | $4.54 |
| 2026-06-17 | $4.38 |
| 2026-06-16 | $4.25 |
| 2026-06-15 | $4.32 |
| 2026-06-12 | $4.33 |
| 2026-06-11 | $4.63 |
| 2026-06-10 | $4.43 |
| 2026-06-09 | $4.54 |
| 2026-06-08 | $4.39 |
| 2026-06-05 | $4.57 |
| 2026-06-04 | $4.69 |
| 2026-06-03 | $4.40 |
| 2026-06-02 | $4.31 |
| 2026-06-01 | $4.28 |
| 2026-05-29 | $3.97 |
| 2026-05-28 | $4.22 |
| 2026-05-27 | $3.93 |
| 2026-05-26 | $3.85 |
| 2026-05-22 | $3.82 |
| 2026-05-21 | $3.91 |
| 2026-05-20 | $3.81 |
| 2026-05-19 | $3.55 |
| 2026-05-18 | $3.65 |
| 2026-05-15 | $3.58 |
| 2026-05-14 | $3.62 |
| 2026-05-13 | $3.73 |
| 2026-05-12 | $4.07 |
| 2026-05-11 | $4.21 |
| 2026-05-08 | $4.29 |
| 2026-05-07 | $4.09 |
| 2026-05-06 | $4.11 |
| 2026-05-05 | $5.03 |
| 2026-05-04 | $4.94 |
| 2026-05-01 | $4.80 |
| 2026-04-30 | $4.75 |
| 2026-04-29 | $4.68 |
| 2026-04-28 | $4.84 |